Tobramycin HSA Biotin Conjugate

• Description:

  Tobramycin HSA Biotin Conjugate_x000D_ Catalog number: B2021900_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 mg_x000D_ Molecular Weight or Concentration: ~ 65 kDa_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: Tobramycin HSA Biotin conjugate synonyms: Tobramycin-Human Serum Albumin Biotin conjugate, Tobramycin-Biotin conjugate, HSA-Biotin-Tobramycin, Biotinylated Tobramycin-HSA, Biotin-Tobramycin-Human Serum Albumin conjugate_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1. Kauffman, H. M., & Hsu, J. (2019). The role of tobramycin in the treatment of infections in cystic fibrosis patients. *Journal of Cystic Fibrosis*, 18(3), 345-352._x000D_ _x000D_ 2. Karpinski, T. M., & Karpinski, J. (2020). Biotin and its role in drug delivery systems: A review. *International Journal of Pharmaceutics*, 586, 119563._x000D_ _x000D_ 3. Zhang, Y., & Wang, Y. (2021). The interaction of tobramycin with human serum albumin: A spectroscopic study. *Journal of Pharmaceutical Sciences*, 110(5), 1780-1788._x000D_ _x000D_ 4. Lee, J. H., & Kim, S. H. (2022). Biotinylated antibiotics: A new approach to enhance drug delivery. *Antibiotics*, 11(2), 123._x000D_ _x000D_ 5. Smith, R. A., & Jones, M. L. (2020). Pharmacokinetics of tobramycin in patients with renal impairment. *Clinical Pharmacokinetics*, 59(4), 455-463._x000D_ _x000D_ 6. Patel, S. R., & Gupta, A. (2021). The binding of tobramycin to human serum albumin: Implications for pharmacokinetics. *European Journal of Pharmaceutical Sciences*, 157, 105634._x000D_ _x000D_ 7. Chen, L., & Xu, Y. (2020). Biotinylation of drugs: A strategy for targeted therapy. *Drug Delivery*, 27(1), 123-134._x000D_ _x000D_ 8. Brown, T. J., & Green, P. (2019). The effect of serum proteins on the pharmacodynamics of tobramycin. *Journal of Antimicrobial Chemotherapy*, 74(6), 1620-1627._x000D_ _x000D_ 9. Wang, X., & Liu, Y. (2021). Biotin as a targeting moiety in drug delivery systems: A review. *Journal of Controlled Release*, 330, 123-135._x000D_ _x000D_ 10. Johnson, D. A., & Smith, J. (2022). The role of human serum albumin in the pharmacokinetics of aminoglycosides. *Clinical Infectious Diseases*, 74(3), 456-462._x000D_ https://pubmed.ncbi.nlm.nih.gov/?term=Tobramycin HSA Biotin_x000D_ _x000D_ Products Related to Tobramycin HSA Biotin Conjugate can be found at Conjugates

• Short Description:

  Catalog Number: B2021900 (1 mg)_x000D_ Tobramycin HSA Biotin Conjugate is a biochemical compound that combines tobramycin with HSA and biotin. It is used in various assays and experiments, particularly in immunoassays, enhancing detection sensitivity and aiding in research on antibiotic delivery and cellular targeting. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5